GPX4 and cancer: Inducing ferroptosis by either inhibition of the cystine/glutamate transporter, SLC7A11 (i.e., erastin) or glutathione peroxidase 4 (GPX4) (i.e., RSL3) has shown promising results in a variety of cancers.